Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

699 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Breast cancer-local treatment-].
Bando H. Bando H. Gan To Kagaku Ryoho. 2011 Dec;38(13):2563-8. Gan To Kagaku Ryoho. 2011. PMID: 22319836 Japanese. No abstract available.
Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01.
Yamashiro H, Iwata H, Masuda N, Yamamoto N, Nishimura R, Ohtani S, Sato N, Takahashi M, Kamio T, Yamazaki K, Saito T, Kato M, Lee T, Kuroi K, Takano T, Yasuno S, Morita S, Ohno S, Toi M; JBCRG-C01 Collaborative Group. Yamashiro H, et al. Breast Cancer. 2020 Jul;27(4):631-641. doi: 10.1007/s12282-020-01057-4. Epub 2020 Feb 14. Breast Cancer. 2020. PMID: 32060785 Free PMC article.
Overnight fasting before lapatinib administration to breast cancer patients leads to reduced toxicity compared with nighttime dosing: a retrospective cohort study from a randomized clinical trial.
Tsuda M, Ishiguro H, Toriguchi N, Masuda N, Bando H, Ohgami M, Homma M, Morita S, Yamamoto N, Kuroi K, Yanagita Y, Takano T, Shimizu S, Toi M. Tsuda M, et al. Among authors: bando h. Cancer Med. 2020 Dec;9(24):9246-9255. doi: 10.1002/cam4.3528. Epub 2020 Oct 23. Cancer Med. 2020. PMID: 33094919 Free PMC article. Clinical Trial.
Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer.
Taira N, Sawaki M, Uemura Y, Saito T, Baba S, Kobayashi K, Kawashima H, Tsuneizumi M, Sagawa N, Bando H, Takahashi M, Yamaguchi M, Takashima T, Nakayama T, Kashiwaba M, Mizuno T, Yamamoto Y, Iwata H, Ohashi Y, Mukai H, Kawahara T; RESPECT Study Group. Taira N, et al. Among authors: bando h. J Clin Oncol. 2021 Aug 1;39(22):2452-2462. doi: 10.1200/JCO.20.02751. Epub 2021 Apr 9. J Clin Oncol. 2021. PMID: 33835842
Characteristics, treatment trends, and long-term outcomes of Japanese patients with pregnancy-associated breast cancer (PABC).
Kataoka A, Ueno T, Yamauchi H, Uehiro N, Takahata C, Takahashi Y, Nakashima E, Ogiya A, Sakai T, Kitagawa D, Morizono H, Miyagi Y, Iwase T, Kitano A, Fukatsu Y, Tamura N, Kawano J, Bando H, Tamaki K, Shiota K, Ozawa M, Kobayashi M, Ohno S. Kataoka A, et al. Among authors: bando h. Breast Cancer. 2022 Sep;29(5):825-834. doi: 10.1007/s12282-022-01362-0. Epub 2022 May 23. Breast Cancer. 2022. PMID: 35604614
Current status of antibody therapy for breast cancer.
Toi M, Takada M, Bando H, Toyama K, Yamashiro H, Horiguchi S, Saji S. Toi M, et al. Among authors: bando h. Breast Cancer. 2004;11(1):10-4. doi: 10.1007/BF02967994. Breast Cancer. 2004. PMID: 14718785 Review.
699 results